Current Advances in Nanocarriers for Cancer Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Pharmacology

Background:

• Nanocarriers offer significant potential for encapsulating and delivering bioactive compounds to target cells.
• Intracellular barriers and drug resistance present major challenges in drug delivery.
• Effective drug delivery is crucial for optimal therapeutic outcomes in various diseases, particularly cancer.

Purpose of the Study:

• To review the challenges posed by drug resistance and cell barriers in nanocarrier-mediated drug delivery.
• To explore recent advances and novel strategies for overcoming these obstacles.
• To provide an overview of nanocarrier types for cancer therapy and their future prospects.

Main Methods:

• Literature review focusing on nanocarrier-based drug delivery systems.
• Analysis of strategies to enhance cell internalization, intracellular trafficking, and targeted delivery.
• Discussion of methods for controlled drug release and overcoming multidrug resistance.

Main Results:

• Nanocarriers can be engineered to navigate intracellular barriers and evade resistance mechanisms.
• Novel strategies improve nanocarrier efficiency in targeting specific subcellular locations.
• Controlled drug release from nanocarriers enhances therapeutic efficacy and reduces side effects.

Conclusions:

• Nanocarriers hold great promise for precise and effective drug delivery in cancer therapy.
• Continued research into nanocarrier design and targeting strategies is essential.
• This review provides insights for developing advanced nanocarriers for diverse therapeutic applications.